344 related articles for article (PubMed ID: 6161001)
1. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Isaacs JT; Coffey DS
Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
[TBL] [Abstract][Full Text] [Related]
2. Dihydrotestosterone concentration of beagle prostatic tissue: effect of age and hyperplasia.
Ewing LL; Berry SJ; Higginbottom EG
Endocrinology; 1983 Dec; 113(6):2004-9. PubMed ID: 6196180
[TBL] [Abstract][Full Text] [Related]
3. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle.
Isaacs JT
J Steroid Biochem; 1983 Jun; 18(6):749-57. PubMed ID: 6191128
[TBL] [Abstract][Full Text] [Related]
4. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate.
Krieg M; Nass R; Tunn S
J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377
[TBL] [Abstract][Full Text] [Related]
5. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
Lloyd JW; Thomas JA; Mawhinney MG
Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
7. Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS; Walsh PC
Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
[TBL] [Abstract][Full Text] [Related]
8. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
9. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: etiological considerations.
Walsh PC
Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
[TBL] [Abstract][Full Text] [Related]
11. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
Isaacs JT; Brendler CB; Walsh PC
J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
Mendoza P; Sánchez C; Contreras HR; Vergara J; Acevedo C; Cabezas J; Huidobro C; Noé G; Castellón EA
Int J Androl; 2009 Dec; 32(6):607-15. PubMed ID: 18637152
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
14. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
[TBL] [Abstract][Full Text] [Related]
16. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
[TBL] [Abstract][Full Text] [Related]
18. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
19. Comparative aspects of prostatic growth and androgen metabolism with aging in the dog versus the rat.
Berry SJ; Isaacs JT
Endocrinology; 1984 Feb; 114(2):511-20. PubMed ID: 6581042
[TBL] [Abstract][Full Text] [Related]
20. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
